جست‌وجوی استاد و پژوهشگر

• Pediatric Oncology
• Molecular Oncology
• Neuroblastoma
• +۳ مورد دیگر

Jaume Mora is a Clinical Professor in the Department of Pediatrics at the University of Barcelona, specializing in Pediatric and Molecular Oncology. He earned a PhD in Molecular Oncology (2003) following residency training in general pediatrics (1992-1995) and a pediatric Hematology/Oncology fellowship at Memorial Sloan Kettering Cancer Center (MSKCC), New York (1996-1998). He later completed a Research Fellowship in molecular pathology at MSKCC (1999-2001) before returning to Barcelona in 2002 as a leader in pediatric oncology. PhD in Molecular Oncology (2003) Residency: General Pediatrics (1992-1995) Fellowship: Pediatric Hematology/Oncology at MSKCC (1996-1998) Research Fellowship: Molecular Pathology at MSKCC (1999-2001) His research focuses on pediatric cancers like neuroblastoma and Ewing sarcoma, with emphasis on molecular pathology, targeted therapies, and cancer immunotherapy. Recent work explores HDAC6 inhibition in Ewing sarcoma, AKT inhibitors for vascular malformations, and extracellular vesicle-mediated tumor-stromal interactions. Key contributions include clinical trials on naxitamab for high-risk neuroblastoma, highlighting its efficacy and safety. His publications span journals like Annals of Oncology , Oncogene , and Translational Research , reflecting interdisciplinary collaboration.

• Biomedical Imaging
• Neurosciences
• Molecular Imaging
• +۶ مورد دیگر

Professor Mark Lythgoe is a distinguished academic at University College London (UCL), where he serves as Professor of Biomedical Imaging in the Department of Imaging within the Faculty of Medical Sciences. He is the Founder and Director of the Centre for Advanced Biomedical Imaging (CABI) at UCL, a multidisciplinary research center hosting 12 state-of-the-art imaging modalities and 50 researchers. Additionally, he is Co-Director of the UCL Department of Imaging and Director of Biomedical Imaging Research at the Francis Crick Institute. Mark Lythgoe earned his Doctor of Philosophy from University College London in 1999 and his Master of Science from the University of Surrey in 1993. Professor Lythgoe has a long-standing track record in the development and application of biomedical imaging techniques, with research spanning from fundamental imaging science to clinical applications. His work focuses on advancing imaging technologies for biomedical research and clinical practice, with particular emphasis on neuroimaging, molecular imaging, and the application of imaging to understand neurological disorders and cancer. He has translated his research findings into clinical radiological practice and established training programs in biomedical imaging. His extensive publication record demonstrates consistent innovation across imaging modalities, with recent work increasingly focused on the glymphatic system in neurological disorders, advanced tumor imaging techniques, and the development of novel imaging technologies for both preclinical and clinical applications. His research bridges engineering, physics, biology, and clinical medicine to solve complex biomedical challenges. Professor Lythgoe's significant contributions to the field have been recognized with numerous prestigious awards: IET Achievement Medal (2023) - for major and distinguished contribution in Medical Imaging Royal Society of Medicine Ellison-Cliffe Award (2021) - for contribution of fundamental science to the advancement of medicine Davies Medal from the Royal Photographic Society (2013) - for significant contribution to imaging science Alumni Achievement Award from the University of Salford Neuroscience Prize for Public Understanding from the British Neuroscience Association Dorothy Hodgkin Award Biosciences Federation Science Communication Award Fellow of the British Science Association Professor Lythgoe has secured substantial research funding, with £45 million awarded for his collaborative imaging research program. He is deeply committed to training the next generation of imaging scientists, serving as Co-Director of the MSc in Advanced Biomedical Imaging and Co-Founder of the UCL Centre for Doctoral Training in Medical Imaging. His public engagement efforts include directing the Cheltenham Science Festival, which has become one of the largest science festivals in the world. As Director of the Centre for Advanced Biomedical Imaging, Professor Lythgoe leads a vibrant research team of 50 researchers working across 12 state-of-the-art imaging modalities. His center fosters interdisciplinary collaboration between engineers, physicists, biologists, and clinicians to develop and apply cutting-edge imaging technologies. He has published over 300 papers including publications in Nature, Nature Photonics, Nature Medicine and The Lancet, demonstrating the high impact of his research across multiple disciplines.

• Molecular Imaging
• Magnetic Resonance Imaging
• Cancer Biomarkers
• +۳ مورد دیگر

Daniel Coman is an Associate Professor of Radiology and Biomedical Imaging and of Biomedical Engineering at Yale School of Medicine. His primary appointment is in the Department of Radiology & Biomedical Imaging with additional affiliations in Bioimaging Sciences, DNA Damage and Genome Integrity, Magnetic Resonance Research Center, and the Yale Cancer Center. Dr. Coman's research focuses on developing molecular imaging methods to reveal physiological and chemical alterations underlying disease in preclinical models and clinical applications. His laboratory utilizes advanced Magnetic Resonance techniques including multi-nuclear MR Spectroscopy (1H, 13C, 31P, 19F, 23Na) and multi-modal MR Imaging approaches such as Biosensor Imaging of Redundant Deviation in Shifts (BIRDS), Chemical Exchange Saturation Transfer, calibrated fMRI, Diffusion Tensor Imaging, and Arterial Spin Labeling. His primary research interest centers on developing new MR imaging biomarkers for cancer to better understand resistance mechanisms and design novel therapies. His recent publications demonstrate a strong emphasis on tumor microenvironment imaging, particularly pH gradients and sodium levels in cancer models. Dr. Coman has made significant contributions through the development of the BIRDS technique for mapping the acidic microenvironment of cancer. His work spans multiple disease areas including brain neoplasms, liver neoplasms, and Alzheimer's disease, with applications in understanding metabolic alterations, immune responses to therapies, and developing advanced imaging biomarkers. Dr. Coman has received the Peterson Fellowship for graduate study in biochemistry from Yale University and maintains extensive collaborations with leading researchers including D. S. Fahmeed Hyder, Sandeep Kumar Mishra, and Julius Chapiro. His research bridges the gap between basic science and clinical applications with a strong translational focus on improving cancer diagnosis and treatment monitoring.

• Developmental Biology
• Cell Biology
• Molecular Biology
• +۳ مورد دیگر

Laura Ahtiainen serves as a Docent in the Molecular and Integrative Biosciences Research Program within the Faculty of Biological and Environmental Sciences at the University of Helsinki. She holds supervisory roles in both the Doctoral Programme in Biomedicine and the Doctoral Programme in Integrative Life Science. Her research focuses on developmental biology mechanisms, particularly in tissue morphogenesis and organ development. Dr. Ahtiainen investigates epithelial signaling centers, cell migration patterns, and molecular pathways governing tooth development, hair follicle formation, and mammary gland morphogenesis. Her work combines cell biological approaches with developmental models to understand fundamental morphogenetic processes. Dr. Ahtiainen has published 23 research articles spanning nearly two decades, with recent work emphasizing signaling centers in molar tooth development. Her publication history demonstrates consistent contributions to developmental biology, with significant papers appearing in high-impact journals including Journal of Cell Biology, Developmental Cell, and Proceedings of the National Academy of Sciences. She actively contributes to the scientific community through peer review activities for journals such as Stem Cells and the International Journal of Breast Cancer, and serves on the Board for Gene Technology in Finland. Dr. Ahtiainen has supervised Master's theses and provided postdoctoral mentorship, demonstrating her commitment to training the next generation of researchers in developmental biology and molecular biosciences.

• Tissue Engineering
• Biomaterials
• Bioprinting
• +۷ مورد دیگر

Annalisa Tirella serves as Associate Professor in the Department of Industrial Engineering at the University of Trento, specializing in biomaterials and tissue engineering. Her research focuses on developing advanced 3D models for cancer microenvironments and regenerative medicine applications, with particular expertise in hydrogel engineering and bioprinting technologies. Her primary research interests include Tissue Engineering , Biomaterials Design , and Cancer Microenvironment Modeling , with emphasis on creating physiologically relevant in vitro systems. She investigates how mechanical properties of biomaterials influence cellular behavior in breast and prostate cancer models, develops sustainable biomaterials from circular economy sources, and engineers drug delivery systems using nano-in-micro technologies. Her TERM (Tissue Engineering and Regenerative Medicine) work bridges fundamental biophysical principles with clinical translation. Dr. Tirella teaches advanced courses including Biotechnology Engineering for the Department of Cellular, Computational and Integrative Biology, where she covers TERM applications, biomaterials characterization, and additive manufacturing techniques. Her educational focus emphasizes problem-solving skills for designing biomedical technologies and understanding cell-biomaterial interactions. Her recent publications (2023-2025) reveal strong trends in cancer microenvironment modeling (particularly breast and prostate cancers), hydrogel engineering with alginate and natural polymers, and advanced drug delivery systems . Key research directions include deciphering invasive cancer phenotypes through data-driven approaches, developing tumor-mimetic scaffolds with tunable mechanical properties, and creating sustainable biomaterials for precision medicine applications. The work consistently integrates biomechanical analysis with biological validation. Dr. Tirella actively develops innovative methodologies including microfluidic fabrication, response surface methodology for hydrogel optimization, and nano-in-micro encapsulation techniques. Her research has significant implications for understanding cancer metastasis mechanisms and developing targeted therapeutic approaches.

Miglena K. Komfortiمشاهده پروفایل

پزشک-پژوهشگر

• Breast Pathology
• Gynecologic Pathology
• Diagnostic Pathology
• +۳ مورد دیگر

Miglena K. Komforti, D.O. is a Physician Scientist in the Department of Laboratory Medicine and Pathology at the Mayo Clinic in Jacksonville, Florida. With expertise in breast pathology , gynecologic pathology , and diagnostic precision , she bridges clinical practice and research. Education: Medical degree (Nova Southeastern University), Fellowship (Montefiore Medical Center, Duke University) Professional Memberships: Florida Society of Pathologists, United States and Canadian Academy of Pathology Research Interests focus on breast cancer diagnostics, HER2 testing, and rare pathologies. Her work addresses challenges in surgical pathology, including acinar/tubule formation in carcinomas and metastatic differentiation. She contributes to immunohistochemistry standardization and multimodal imaging correlation . Scientific Awards : Above and Beyond Teamwork Award (2024) Above and Beyond Recognition Program (2024) Employee Recognition Program (2023) Mentorship includes guiding a Phlebotomy student toward anatomic pathology and contributing to educational case studies (e.g., Ductal Carcinoma In Situ). Her publications span breast tumor biology , endometrial cancer , and rare clinical-pathological phenomena .

Maciek R. Antoniewiczمشاهده پروفایل

استاد

• Metabolic Engineering
• Systems Biology
• Cancer Metabolism
• +۳ مورد دیگر

Professor Maciek R. Antoniewicz is a faculty member in the Department of Chemical Engineering at the University of Michigan. He leads the Antoniewicz Laboratory for Metabolic Engineering and Systems Biology, which develops next-generation tools and techniques for analyzing, engineering and manipulating microbial and mammalian systems applied to specific problems in biotechnology and medicine. Dr. Antoniewicz's research focuses on metabolic engineering, biotechnology, cancer metabolism, and microbial communities. His laboratory makes use of modern techniques for cell culture, 13C metabolic flux analysis, mass spectrometry, molecular biology, bioinformatics and computational biology. Current research interests include elucidating syntrophic interactions in microbial communities, analysis of compartment-specific fluxes in mammalian cells, dynamic flux analysis, cancer metabolism, and engineering microbes for enhanced utilization of renewable substrates and production of value-added chemicals. His recent publications demonstrate a strong trend toward developing and applying metabolic flux analysis techniques across diverse biological systems, from microbial communities to cancer cells. The work spans fundamental methodology development to applied biotechnology problems, with particular emphasis on 13C metabolic flux analysis and systems-level understanding of cellular metabolism. Dr. Antoniewicz has received numerous prestigious awards including: Elected Fellow, American Institute for Medical and Biological Engineering (AIMBE), 2018 National Academy of Engineering (NAE) US-EU, Frontiers of Engineering Participant, 2017 Biotechnology and Bioengineering Daniel I.C. Wang Award, 2015 Gerard J. Mangone Best Young Scholar Award, 2012 NSF CAREER Award, 2011 DuPont Young Professor Award, 2008 James E. Bailey Young Investigator Award in Metabolic Engineering, 2008 Dr. Antoniewicz has advised numerous PhD and Master's students who have gone on to win awards and secure prestigious positions. His research has been supported by significant grants from NSF, DOE, and other agencies, including a recent $1.5M DoE grant to study microbiomes with Professors Lin and Allman. He has also received grants to study fatty acid metabolism and dipeptide metabolism in CHO cells. The Antoniewicz Laboratory maintains state-of-the-art facilities for both microbial and mammalian cell culture, including advanced mass spectrometry equipment for metabolic flux analysis. The laboratory is equipped with multiple bioreactor systems, cell culture facilities, and analytical instruments that support cutting-edge research in metabolic engineering and systems biology.

Christina Baikمشاهده پروفایل

دانشیار

• Lung Cancer
• Thoracic Oncology
• Targeted Therapies
• +۳ مورد دیگر

Christina Baik, M.D., M.P.H. is an Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and an Associate Professor in the Clinical Research Division at Fred Hutch Cancer Center. She serves as Clinical Research Director for Thoracic and Head and Neck Oncology at UW Medicine and practices at Fred Hutch Cancer Center locations in South Lake Union and UW Medical Center – Montlake. Dr. Baik received her medical degree from the University of Rochester School of Medicine, completed her residency in Internal Medicine at Brown University Medical School, and pursued fellowship training in Hematology/Oncology at Tufts Medical Center. She furthered her research training with a post-doctoral fellowship at Fred Hutchinson Cancer Research Center and earned a Master of Public Health from Harvard School of Public Health. Her research focuses on developing targeted therapeutics for oncogene-driven lung cancer, with particular interest in understanding mechanisms of primary and secondary resistance to immunotherapy. Dr. Baik leads multiple clinical trials evaluating the efficacy of small molecular inhibitors in lung cancer treatment. Her publication record shows consistent research output spanning from 2010 to 2025, with recent work emphasizing novel therapeutic approaches for EGFR-mutant and other molecularly defined lung cancers. Dr. Baik's clinical expertise centers on thoracic oncology, particularly lung cancer treatment. She treats patients with thoracic and head and neck malignancies at the UW/Fred Hutchinson Cancer Center and is actively involved in educating medical students, residents, and fellows.

Yazan Alwarawrahمشاهده پروفایل

استادیار

• Immunometabolism
• T cell biology
• Obesity-related immune dysfunction
• +۴ مورد دیگر

Dr. Yazan Alwarawrah is an Assistant Professor of Pediatrics at the University of North Carolina at Chapel Hill School of Medicine, specializing in Pediatric Endocrinology. His research focuses on the intersection of immunology and metabolism, with particular emphasis on how obesity affects immune function and the development of metabolic interventions for immune-related pathologies. Undergraduate: Al Al-Bayt University, Mafraq, Jordan Master of Science: Yarmouk University, Irbid, Jordan Doctor of Philosophy: Pharmacology, Duke University Dr. Alwarawrah's primary research interests center on immunometabolism, particularly how metabolic pathways regulate immune cell function in obesity and disease states. His work investigates T cell metabolism in the context of obesity-associated immune dysfunction, with specific focus on protective immunity against influenza. He also studies the role of Immunity Related GTPase I (Irgm1) in regulating T cell metabolism and function, and explores metabolic engineering approaches to enhance chimeric antigen receptor (CAR) T cell persistence in tumor microenvironments. His diverse scientific background spans molecular biology, bioinformatics, pharmacology, and immunology. Analysis of Dr. Alwarawrah's publication record reveals a strong focus on the intersection of metabolism and immunity, particularly in obesity contexts. His work spans fundamental mechanisms of immune cell metabolism to translational applications in infectious disease, cancer, and autoimmune conditions. Key themes include T cell metabolic dysfunction in obesity, macrophage metabolism, and pharmacological targeting of metabolic pathways for therapeutic benefit. His research employs diverse approaches including diet-induced obesity mouse models, metabolic and flow cytometric analyses, and pharmacological interventions. Dr. Alwarawrah's research program bridges basic science and clinical applications, with implications for treating obesity-associated pathologies, cancer, and autoimmune diseases through metabolic interventions. His work on T cell metabolism in obesity has particular relevance for understanding impaired immune responses in metabolic disease states. While specific grant information isn't detailed in the provided materials, his research trajectory suggests involvement in NIH-funded projects related to immunometabolism and obesity.

Teresa A. Zimmersمشاهده پروفایل

استاد

• Cancer Cachexia
• Pancreatic Cancer
• Muscle Wasting and Atrophy
• +۷ مورد دیگر

Teresa A. Zimmers is a Professor at Indiana University with extensive expertise in cancer cachexia, muscle wasting, and translational oncology. She holds a Ph.D. from The Johns Hopkins University School of Medicine (2001), a B.S. from Massachusetts Institute of Technology (1990), and completed postdoctoral training at the University of Rochester (2001-2003). Dr. Zimmers leads prominent academic initiatives as President of the Cancer Cachexia Society and co-organizer of international conferences including the 2023 Cancer Cachexia Conference and 2024 Keystone Conference. Her multidisciplinary research focuses on: Molecular mechanisms of cancer cachexia and muscle atrophy Sex-specific differences in cancer progression Pancreatic cancer pathophysiology Inflammatory signaling in organ injury Translational approaches for metabolic wasting disorders She maintains active memberships in the American Association for Cancer Research, Shock Society, and Society on Sarcopenia, Cachexia and Wasting Diseases. Honors recognizing her contributions include: Alliance of Distinguished and Titled Professors (Indiana University, 2019) Sigma Xi Honor Society (2019) Cancer Researcher of the Year (Women’s Cancer Association, 2009) Distinguished Investigator Award (University of Miami, 2005)

Vijay Kumarمشاهده پروفایل

استادیار

• Tumor Immunology
• Immunotherapy
• Innate Immunity
• +۳ مورد دیگر

Vijay Kumar, PhD, serves as an Assistant Professor in the Department of Surgery at Morehouse School of Medicine, where he directs the Laboratory of Tumor Immunology and Immunotherapy. His research focuses on tumor immunology and immunotherapy with emphasis on innate immune mechanisms and the tumor microenvironment. His academic background includes: PhD in Immunology and Medical Microbiology from Panjab University MSc in Toxicology from Hamdard University BSc in Botany, Zoology, and Chemistry from DAV College Dr. Kumar's research centers on understanding immune dysregulation in cancer, particularly through Toll-like receptors and macrophage biology. His work explores how inflammation and immune homeostasis influence tumor progression, aiming to develop novel immunotherapeutic strategies. Recent editorial contributions demonstrate expertise in translating fundamental immunological concepts into clinical applications, with significant focus on methodological advances in immune protocols. His publication record (2017-2024) reveals consistent scholarly output in immunological mechanisms, showing evolution from foundational topics like sepsis and vaccines toward contemporary cancer immunology. Key trends include historical perspectives on immunological discoveries (e.g., 140 years of macrophage research, 30 years of Toll-like receptor studies) and methodological frameworks for immune homeostasis in tumor contexts. No scientific awards were mentioned in the provided documentation. Information regarding student advising, grant funding, or specific mentorship activities was not provided in the available text, though his faculty position implies involvement in academic supervision within the Department of Surgery. Dr. Kumar leads the Laboratory of Tumor Immunology and Immunotherapy, which investigates immune cell interactions within the tumor microenvironment. The lab's work integrates historical immunological perspectives with modern therapeutic approaches, focusing on restoring immune homeostasis as a strategy for cancer treatment.

Jamie Yam Auxillosمشاهده پروفایل

استادیار

• Molecular Biology
• Synthetic Biology
• Biotechnology
• +۵ مورد دیگر

Jamie Yam Auxillos is an Assistant Professor at the University of Copenhagen, affiliated with both the Biotech Research & Innovation Centre (BRIC) and the Department of Biology, where she leads research in Computational and RNA Biology. Her work bridges molecular biology, synthetic biology, and cutting-edge sequencing technologies. Education: PhD in Cell and Molecular Biology (2020), Centre for Systems and Synthetic Biology, University of Edinburgh MSc in Systems and Synthetic Biology (2015), University of Edinburgh BSc Honours in Biomedical Sciences with Medical Microbiology (2014), Newcastle University Dr. Auxillos' research focuses on Molecular Biology, Synthetic Biology, and Biotechnology , with particular expertise in Sequencing Methods Development, Spatial Transcriptomics, and Nanopore long read sequencing. Her work combines computational approaches with experimental techniques to develop new methods for RNA analysis and to understand complex biological systems, particularly in cancer biology and synthetic yeast engineering. Her recent publications reveal a strong trend toward developing innovative sequencing methodologies and applying them to cancer research, with significant contributions to spatial transcriptomics and tumor microenvironment analysis. She has also made important contributions to synthetic biology tools, particularly for yeast engineering and CRISPR-based technologies. Dr. Auxillos has established collaborative networks across multiple countries and institutions, with significant research output including journal articles, reviews, and book chapters that have garnered substantial attention across academic and social media platforms. Her research has been shared widely, with publications posted by numerous X (Twitter) users, featured on Facebook pages, discussed on Reddit, referenced in policy sources and patents, and read by hundreds of researchers on Mendeley.

• Cancer Research
• Uveal Melanoma
• Melanoma
• +۵ مورد دیگر

Aaron Beasley is a Research Fellow at the School of Medical and Health Sciences, Edith Cowan University , leading the Cancer Genomics research group within the Centre for Precision Health . His research focuses on Uveal Melanoma, Melanoma, and liquid biopsy techniques for cancer detection. Doctor of Philosophy (2021) , Edith Cowan University Master of Science (Human Biology, 2017) , Edith Cowan University Bachelor of Science (Biomedical Science, 2014) , Edith Cowan University His work spans Next Generation Sequencing, circulating tumour DNA (ctDNA), and circulating tumour cells (CTCs) across Ovarian Cancer, Lung Cancer, and Melanoma . Recent publications highlight applications of Spatial Transcriptomics, Single-Cell Genomics, and T-cell Receptor (TCR) Repertoire Analysis in tumor heterogeneity and immunotherapy response prediction. Grants include funding from the Cancer Research Trust ($1,167,284) and Spinnaker Health Research Foundation for projects on melanoma brain metastases and immunotherapy resistance . He supervises PhD students exploring TCR/HLA interactions, Tumour-Infiltrating Lymphocytes, and multi-omics approaches to cancer diagnostics.

• Pharmacology
• Pharmaceutical Science
• Drug Metabolism
• +۳ مورد دیگر

Anne Filppula is a Senior University Lecturer at the Faculty of Science and Engineering , Department of Pharmacy Solutions for Health at Åbo Akademi University. She holds a PhD and a Docent title in translational drug research from the University of Helsinki. Her research focuses on drug metabolism, pharmacogenetics, and innovative drug delivery systems, particularly involving CYP enzymes and drug-drug interactions. Key research areas include Clopidogrel pharmacokinetics , metabolism of CYP2C8 substrates , and hydrogel-based therapies . She has contributed to projects like the Nordic Pharmaceutical Translation and Innovation (2024–2028) and Nordic POP (2018–2025), emphasizing patient-oriented pharmaceutical solutions. Her recent publications highlight advancements in extrusion-based drug formulation , mitochondrial transplantation , and hydrogel-responsive biomaterials . She actively participates in academic activities such as the 1st Helsinki Organ-on-a-chip meeting and serves on examination boards for doctoral defenses. Education: PhD in Pharmacy, Docent in Translational Drug Research (University of Helsinki) Projects: Co-PI in Nordic-funded pharmaceutical innovation initiatives Grants: NordForsk-supported research programs Labs/Teams: Involved in Pharmacy Solutions for Health research groups

Rui Chenمشاهده پروفایل

پژوهشگر

• Genomics
• Machine Learning
• Cancer Biology
• +۳ مورد دیگر

Rui Chen, PhD, is a Researcher in the Department of Molecular Physiology and Biophysics at Vanderbilt University School of Medicine. Their work focuses on integrating multi-omics data with advanced computational methods to uncover genetic mechanisms in complex diseases, including schizophrenia, cancer, and neurodevelopmental disorders. Dr. Chen’s research emphasizes leveraging machine learning for precision medicine applications, such as predicting cancer outcomes and identifying druggable genes. Key areas of expertise include functional genomics, Bayesian statistical frameworks, and computational tool development for genomic data quality control (e.g., the DRAMS tool). Their studies often bridge basic science and clinical translation, using zebrafish models and biobank resources for disease discovery. Dr. Chen has contributed to advancements in understanding gene regulatory networks in plants (e.g., rice stamen development) and has pioneered methods for analyzing non-coding variants using deep learning. Their work consistently addresses translational challenges in genetics, such as improving rare variant association studies and refining GWAS interpretations through multi-omics integration. Contact: rui.chen.1@vanderbilt.edu